The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Carlos María Galmarini

Unité INSERM 453-Laboratoire de Cytologie Analytique

Faculté de Médécine Rockefeller

France

[email]@*.univ-lyon1.fr

Name/email consistency: medium

 
 
 
 
 
 
 

Affiliations

  • Unité INSERM 453-Laboratoire de Cytologie Analytique, Faculté de Médécine Rockefeller, France. 2001 - 2004
  • INSERM 453. 8 Avenue Rockefeller, 69373 Lyon Cedex 08, France. 2003 - 2004
  • INSERM 590, University Claude Bernard Lyon 1, 8 Avenue Rockefeller, 69373 Lyon, France. 2004
  • Division Medicina, Hospital Municipal de Oncologia María Curie, Buenos Aires, Argentina. 2002

References

  1. Canertinib pfizer. Galmarini, C.M. IDrugs (2004) [Pubmed]
  2. Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene. Galmarini, C.M., Clarke, M.L., Jordheim, L., Santos, C.L., Cros, E., Mackey, J.R., Dumontet, C. BMC Pharmacol. (2004) [Pubmed]
  3. OSI-461 (OSI). Galmarini, C.M. Curr. Opin. Investig. Drugs (2004) [Pubmed]
  4. Histamine dihydrochloride (subcutaneous) Maxim. Galmarini, C.M. Curr. Opin. Investig. Drugs (2004) [Pubmed]
  5. Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine. Galmarini, C.M., Voorzanger, N., Falette, N., Jordheim, L., Cros, E., Puisieux, A., Dumontet, C. Biochem. Pharmacol. (2003) [Pubmed]
  6. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics. Galmarini, C.M., Kamath, K., Vanier-Viornery, A., Hervieu, V., Peiller, E., Falette, N., Puisieux, A., Ann Jordan, M., Dumontet, C. Br. J. Cancer (2003) [Pubmed]
  7. Sensitization of ara-C-resistant lymphoma cells by a pronucleotide analogue. Galmarini, C.M., Clarke, M.L., Santos, C.L., Jordheim, L., Perigaud, C., Gosselin, G., Cros, E., Mackey, J.R., Dumontet, C. Int. J. Cancer (2003) [Pubmed]
  8. Pyrimidine nucleoside analogs in cancer treatment. Galmarini, C.M., Jordheim, L., Dumontet, C. Expert. Rev. Anticancer. Ther (2003) [Pubmed]
  9. EPO-906 (Novartis). Galmarini, C.M., Dumontet, C. IDrugs (2003) [Pubmed]
  10. Multidrug resistance in cancer therapy: role of the microenvironment. Galmarini, C.M., Galmarini, F.C. Curr. Opin. Investig. Drugs (2003) [Pubmed]
  11. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine. Galmarini, C.M., Clarke, M.L., Falette, N., Puisieux, A., Mackey, J.R., Dumontet, C. Int. J. Cancer (2002) [Pubmed]
  12. Oral ftorafur plus intramuscular thiotepa as adjuvant chemotherapy in patients with breast cancer. Galmarini, C.M., Garbovesky, C., Galmarini, D., Galmarini, F.C. Med. Oncol. (2002) [Pubmed]
  13. Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Galmarini, C.M., Graham, K., Thomas, X., Calvo, F., Rousselot, P., El Jafaari, A., Cros, E., Mackey, J.R., Dumontet, C. Blood (2001) [Pubmed]
 
WikiGenes - Universities